• Third-party batch reports
  • Public COA ledger
  • Lot-level traceability
  • Ships from Orlando, FL
  • Free US shipping over $100
  • 30-day money-back on unopened products
  • For laboratory & research use
Quality & Testing

Mass Balance: How a Purity Number Is Actually Assembled

· Revoryn Labs

A small peptide vial on an analytical balance pan beside a stack of printed sheets, Revoryn Labs Research Library

Chromatographic purity is a ratio: the target peak as a share of the peptide-related peaks. It is easy to produce and easy to read, and it does not tell you what fraction of the vial is peptide. The figure that does is assembled differently, by a procedure called mass balance, and understanding how it is built explains both why it is more useful and why it is harder to pin down.

Quick answer

What is mass balance purity? It is a purity figure obtained by subtraction rather than by a single measurement: start at 100% of the material's mass, then subtract everything measured that is not the target peptide — water, counterion, residual solvent, inorganic residue and chromatographic impurities. What remains is assigned as the peptide. Pharmacopoeial practice uses exactly this approach; a published multi-laboratory study notes that peptide reference standard content is typically determined by an HPLC assay against an external standard whose purity was determined by a mass balance approach. Because the result is a difference between several independent measurements, it inherits the uncertainty of all of them.

The subtraction, term by term

Term Typical method What it accounts for
Water content Karl Fischer titration Residual moisture, which is mass that is not peptide and varies with the drying cycle
Counterion content Ion chromatography or titration Trifluoroacetate or acetate bound to basic residues. Can be substantial on peptides with several of them.
Residual solvent Headspace gas chromatography Organic reagents left from synthesis and purification
Inorganic residue Residue on ignition / sulfated ash Non-volatile inorganic material
Peptide-related impurities Reversed-phase HPLC area percent Deletion and truncation sequences, oxidation products, isomers

Only the last row is the number most certificates lead with. The first four are the ones that convert a ratio into an absolute quantity, and they are each covered in more detail in residual solvents and water content and TFA versus acetate salts.

Why a subtraction behaves differently from a measurement

Two properties of this construction matter.

Uncertainties accumulate

Each term is an independent determination with its own error. Subtracting four or five of them from 100% produces a result whose uncertainty is larger than any single contributor's. A purity figure assembled this way is not more precise than its least precise term; it is less precise than all of them.

Anything not measured is silently counted as peptide

This is the structural weakness. Mass balance assigns to the peptide whatever is left after the measured terms are removed. A component nobody tested for does not appear as a deficit — it appears as peptide. If a residual solvent panel was not run, that solvent's mass is attributed to the product.

This is the mirror image of the problem described in what not detected actually means. There, an unstated detection limit makes an absence uninterpretable. Here, an unperformed measurement makes a mass balance figure optimistic by exactly the amount that was never looked for.

Why this matters for the numbers above it

A mass balance purity does not usually stay in its own box. It becomes the assigned value of a standard, and that standard then calibrates an HPLC assay used to quantify other material. The published study referenced above makes the chain explicit, and also notes that when inter-laboratory variability was reported for that HPLC assay, the coefficient of variation was calculated without counting the uncertainty associated with the mass balance purity assignment.

So the largest and least tractable uncertainty in the chain is the one most likely to be omitted from the headline figure. We trace that result in how much quantification methods actually agree, and the standards themselves in reference standards.

How to read a certificate with this in mind

  • Check whether net peptide content is reported at all. If it is, the subtraction has been done for you. If only HPLC purity appears, it has not — see net peptide content versus purity.
  • Count which terms are present. Water and salt form are the two largest corrections and the two most commonly available. Their absence is the gap worth asking about.
  • Treat a missing term as mass attributed to the peptide, not as mass that is absent. This reframing is the practical content of this article.
  • Do not add precision that is not there. A mass balance result quoted to two decimal places is reporting more resolution than a five-term subtraction supports.
  • Compare lots within one supplier where the same terms were measured the same way, rather than headline figures across suppliers where the construction may differ entirely.

What is reasonable to expect

A full mass balance is pharmacopoeial practice, not research-supply practice, and expecting one on a research certificate is unrealistic. What is reasonable is water content, salt form, and a clear statement of what the quoted purity figure actually is — a chromatographic ratio or an absolute content. Those two words change the meaning of the number entirely, and they cost nothing to state.

Where the certificate stops, your own measurement starts. Measuring concentration against a reference you control captures water, counterion and everything else in a single number, which is why it remains the highest-value step available to a buyer — see measuring peptide concentration.

Key takeaways

  • Mass balance assigns purity by subtracting measured non-peptide components from 100%, rather than by measuring the peptide directly.
  • The usual terms are water, counterion, residual solvent, inorganic residue and chromatographic impurities.
  • Because the result is a difference between independent measurements, its uncertainty is larger than that of any single term.
  • Anything not measured is silently attributed to the peptide. An unperformed test makes the figure optimistic, not uncertain.
  • Pharmacopoeial peptide standards have their purity assigned this way, and that assignment's uncertainty is often excluded from reported inter-laboratory variability.
  • Chromatographic purity is a ratio; mass balance purity is an absolute content. A certificate should say which it is quoting.
  • Water content and salt form are the two largest and most obtainable corrections. Their absence is the gap worth asking about.

Frequently asked questions

Is mass balance better than HPLC purity?

It answers a different and usually more useful question — how much of the vial is peptide, rather than how much of the peptide-related material is the target. It is also harder to produce and carries more accumulated uncertainty. Neither replaces the other.

Why not just measure the peptide directly?

Direct absolute measurement needs either a characterised reference material of the same substance or a primary method such as quantitative NMR against a certified internal standard. The first is circular and the second is not yet routine for peptides, which is why subtraction remains the common route.

Does a high mass balance purity guarantee accuracy?

No. It guarantees that the terms which were measured summed to a small total. A result of 95% with five terms measured is a stronger claim than 99% with two, because the second has more unexamined mass available to be misattributed.

Where does ash or residue on ignition come in?

It captures non-volatile inorganic material that none of the other terms would see. It is a small term for most synthetic peptides and is often omitted, which is reasonable — but omitting it still means that mass, whatever it is, counts as peptide.

Should I calculate my own mass balance?

Not usually, because the individual determinations need instrumentation most buyers do not have. The accessible equivalent is measuring the concentration of a reconstituted solution against a reference, which captures the combined effect of every non-peptide component in one step.

Sources

  • Li C, Bhavaraju S, Thibeault MP, Melanson J, Blomgren A, Rundlöf T, et al. Survey of peptide quantification methods and comparison of their reproducibility: a case study using oxytocin. J Pharm Biomed Anal. 2019;166:105–112. DOI
  • International Council for Harmonisation. ICH Q3C(R8): Impurities — Guideline for Residual Solvents. ICH guideline

Journal citation retrieved via PubMed.

This article describes analytical documentation only. It contains no usage instructions, no dosing information and no protocols of any kind.

For laboratory and in-vitro research use only. Not for human or veterinary use.

For laboratory and in-vitro research use only. Not for human or veterinary use. See our research-use disclaimer.